- Research article
- Open Access
- Open Peer Review
Under-reporting of foetal alcohol spectrum disorders: an analysis of hospital episode statistics
BMC Pediatricsvolume 11, Article number: 14 (2011)
Internationally, 0.97 per 1,000 live births are affected by foetal alcohol syndrome (FAS). However, prevalence intelligence has been limited in the UK, hindering the development of appropriate services. This analysis compares hospital admissions over time, between regions and with alcohol-related admissions for adult females to assess whether established patterns (such as the North experiencing elevated harms) can be identified.
A retrospective analysis of hospital admissions data (April 2002 to March 2008) for foetal alcohol spectrum disorder (FASD)-related conditions: foetal alcohol syndrome (dysmorphic) (n = 457); foetus and newborn affected by maternal use of alcohol (n = 157); maternal care for (suspected) damage to foetus from alcohol (n = 285); and 322,161 women admitted due to alcohol-related conditions.
Whilst the rate of admission for alcohol-related conditions in women aged 15-44 years increased significantly by 41% between 2002/03 and 2007/08 (p < 0.0001), significant increases were only seen in the numbers of FAS. Established regional rates of admission for alcohol-related conditions in women aged 15-44 years old were not associated with admission for FASD-related conditions.
It would be expected that the North West and North East regions, known to have higher levels of alcohol harm would have higher levels of FASD-related conditions. However, this was not reflected in the incidence of such conditions, suggesting under-reporting. With incomplete datasets, intelligence systems are severely limited, hampering efforts to develop targeted interventions. Improvements to intelligence systems, practitioner awareness and screening are essential in tackling this.
Worldwide estimates suggest that 0.97 per 1,000 live births are affected by foetal alcohol syndrome (FAS) , representing a significant cost to health services, with each affected baby estimated to cost a mean of $2,842 annually . However, long-term costs may be much higher; FAS is associated with psychiatric problems, drug and alcohol addiction, memory and attention deficits [3, 4], thus affecting a range of services including criminal justice, education as well as impacting on the family and local community. In the United Kingdom (UK), prevalence data are limited. Five UK studies contributed to the worldwide estimate; none identified FAS but they were restricted in sample size and geographic representation [1, 5–10]. Subsequently, an analysis of Hospital Episode Statistics (HES) reported 128 cases in 2002/03 in England . However, alcohol-related harm has since escalated [11, 12].
Rates of alcohol related hospital admission for alcohol-related liver disease increased by over 100% between 1989/90 and 2002/03 in England and Wales . Women are particularly at risk of alcohol-related harm due to biological and social factors [13–15]. For example, women are more likely to pre-load than men, a behaviour associated with higher risk of alcohol-related harm [15, 16]. Such risk factors are of particular importance in the early stages of pregnancy, when the risks may be higher (the National Institute for Health and Clinical Excellence advises abstinence in the first three months)  and women are less likely to be aware of their pregnancy status. Levels of consumption are significant in young women, with one study in North West England showing that female nightlife users reported an average consumption of 16.5 units in one night, five times the recommended daily maximum of three units . Even low levels of alcohol consumption, especially if consumed regularly, may affect health. Of women admitted to hospital for unspecified liver cirrhosis in England in 2005/06, 44.4% were estimated to drink from 0.1 to 2.4 units per day . With no clear guidance on alcohol consumption in pregnancy and no established dose related threshold to distinguish between safe and harmful levels of consumption [3, 20], pregnant women can be confused by advice around alcohol consumption , increasing the potential risk for alcohol misuse and the development of conditions such as FAS. However, without adequate monitoring of prevalence of these conditions, it is no possible to establish the true impact of consumption on unborn children in the UK.
We explore the reporting on foetal alcohol spectrum disorder (FASD) related disorder in England using HES. Hospital admissions were compared over time, between regions and with alcohol-related hospital admissions for adult females. We assess whether known geographical patterns in alcohol related harms (for example, whereby the North experiences elevated levels of alcohol-attributable hospital admissions and incapacity benefits claimants for alcoholism) are reflected in FAS-related admission.
HES is a data warehouse containing details of all admissions to National Health Service (NHS) hospitals in England, as well as NHS funded inpatient care provided by independent treatment centres. Each record relates to an episode of care under a single consultant or medical team. Up to 20 diagnoses can be recorded for each episode (increasing from 14 in 2007/08). Diagnoses are coded using the International Classification of Diseases, 10th revision (ICD10). We used 4-digit ICD10 codes to identify inpatient episodes: O35.4, maternal care for (suspected) damage to foetus from alcohol; P04.3, foetus and newborn affected by maternal use of alcohol; and Q86.0, FAS (dysmorphic). Using HES for the UK financial years (April to March) 2002/03 to 2007/08, we identified episodes of care where any one of these diagnoses was recorded. Details extracted included: age at start of episode; sex; Government Office Region (GOR) of residence (from nine across England); and person identifier (HESID). The person identifier is a derived variable that links episodes of care to the same individual (based on NHS number and other identifiers), and which can be used to exclude repeat admissions for the same individual. Using the person identifier, we estimated the number of individuals who were admitted to hospital with each condition in each financial year. This measure combines incident and prevalent cases arising in a 12 month period, and allowed us to assess regional and temporal reporting trends in admission rates which were free from potential distortions arising from multiple hospital episodes in the same individual.
For admissions for foetus and newborn affected by maternal use of alcohol (ICD10 P04.3), we calculated rates using the number of live births in the relevant year as the denominator . Live births were also used as the denominator for admission rates for maternal care for (suspected) damage to foetus from alcohol (O35.4). For FAS (Q86.0), since a diagnosis is often not made until later in childhood [3, 23], we calculated hospital admission rates for children aged up to 14 years, and used mid-year population estimates for children aged up to 14 years as denominators. Here, we excluded 50 episodes involving patients aged 15 or over.
In addition, we used HES to estimate the number of women aged 15-44 years who were admitted to hospital with an alcohol-related diagnosis from 2002/03 to 2007/08. The methods used for this are described in detail elsewhere , but involve identifying numbers of individuals admitted with a range of alcohol-related conditions. For each condition, an alcohol-attributable fraction (AAF) was applied, which represents the proportion of cases where all alcohol cases are alcohol-related by definition and the AAF equals 1 (or 100%). It also includes conditions where alcohol is a contributory factor in only a proportion of cases, for example road traffic accidents (AAF: 0.09-0.21 for females aged 15-44 years), and cancers of the lip, oral cavity and pharynx (AAF: 0.35-0.40). Rates were calculated using mid-year population estimates for women aged 15-44 years as denominators. The rates provide a proxy measure of overall levels of alcohol-related harm in women of childbearing age, and can be compared with admission rates for FASD and related conditions in children.
HES also contains data for NHS outpatient appointments, and we examined the reporting of FASD-related conditions here for 2003/04 to 2007/08 . However, because it is not mandatory for providers to code diagnoses on outpatient records, the completeness of the diagnosis fields is very low. Of 54 million outpatient appointments recorded in 2007/08, less than 3% of outpatient episodes have a valid diagnosis field , and we therefore predicted that these data would be unsuitable for assessing regional or temporal trends in FASD-related conditions. In fact, no cases were identified from the outpatient records and so no analysis was possible.
Trends in reporting over time and between regions were assessed using Poisson regression models, with likelihood ratio tests used to assess temporal and regional variation. We examined associations between regional admission rates for FASD-related conditions and alcohol-related harm in women of childbearing age using Pearson's correlation coefficient. Analyses were performed using Stata 10. Ethical approval was not required , as secondary analysis of HES data can be used to identify public health issues and for general medical research under existing protocols. All analyses performed complied with these regulations .
Between 2002/03 and 2007/08, there were 987 episodes with a diagnosis of FAS (ICD10 code Q86.0) involving 457 children aged under 15 years (Tables 1 and 2). Around 36% of children were aged under 1 at the time of admission (Table 2). The number of persons admitted increased substantially in 2006/07, relative to earlier years, and remained high in 2007/08. The overall trend was highly significant (p = 0.0001). Table 3 shows there were significant variations in regional rates (p < 0.0001 for heterogeneity). The North West had the highest rate of admissions at 1.67 (95%CIs: 1.39-1.99) per 100,000 population, while the lowest rates were seen in the North East (0.41 per 100,000; 95%CIs: 0.21-0.74).
There were 356 episodes with a diagnosis of foetus and newborn affected by maternal use of alcohol (ICD10: P04.3) between 2002/03 and 2007/08, involving 285 individuals (Tables 1 and 2). Nearly all (99%) were aged under one year when admitted (Table 2). The number of persons admitted increased by 59%, from 32 in 2002/03 to 51 in 2007/08, but this trend was not statistically significant (p = 0.22). The rate of admissions varied significantly (p = 0.025) between regions, ranging from 1.8 per 100,000 live births in London (95%CIs: 0.4-5.2) to 5.8 per 100,000 live births in the East Midlands (95%CIs: 3.4-9.3; Table 3). However, the region of residence was missing for 47% of the patients, so that the overall rate for England was higher than any of the regional rates at 7.8 per 100,000 live births (95%CIs: 6.9-8.7).
There were 184 episodes of maternal care for (suspected) damage to the foetus from alcohol (ICD10: O35.4) in England, involving 157 individuals (Tables 1 and 2). A quarter were women aged 15-24 years and the remainder were over 24 years. The number of persons admitted between 2002/03 and 2007/08 increased by 63% from 19 in 2002/03 to 31 in 2007/08 but the overall trend was not statistically significant (p = 0.16). There was significant regional variation in rates (p = 0.0001), ranging from 1.7 per 100,000 live births in London (95%CIs: 0.9-3.0) to 7.2 in the East Midlands and South West (Table 3).
Admission rates for alcohol related conditions in women aged 15-44 increased by 41% between 2002/03 and 2007/08 from 418 to 591 per 100,000. This increase was highly significant (p < 0.0001). Admission rates ranged from 757 [747-767] per 100,000 women aged 15-44 years in the North East regions to 375 [372-379] per 100,000 in London (Table 3). There was no significant correlation between the regional admission rates for alcohol-related harm in women and admissions for the three alcohol-related diagnoses involving children or pregnant women.
It is extremely difficult to accurately estimate the prevalence of disorders such as FASD. There is uncertainty as to the level of maternal alcohol consumption that can cause FASD-related damage , and it can be difficult to obtain a valid understanding of consumption during pregnancy  as alcohol consumption amongst pregnant women is a highly sensitive area. In fact, experts in the United States of America suggest that the stigma attached to such disorders could reduce the likelihood of a diagnosis . However, even without any associated stigma, diagnosis is difficult, not only due to the specialist training required [28, 29] but also because affected individuals may have other diagnosable disorders or secondary disabilities , making it difficult to isolate FASD. Passive surveillance systems, such as HES used in this analysis, also present limitations. Intelligence may be restricted because systems rely on correct diagnosis by a large number of different medical practitioners . Furthermore, trends in hospital data may be influenced by differential access and changes in service provision , as well as relying on individuals to have a reason to require hospital admission.
The HES data show an overall rate of hospital admission for FAS to be 0.84 per 100,000 population in England from 2002/03 to 2007/08. However, such figures cannot be used to measure prevalence as they can only capture intelligence on individuals admitted to hospital within a given year. Thus, other data collection methods (including clinical and epidemiological studies) produce higher incidence estimates, with worldwide estimates for FAS at 0.97 per 1,000 , and more recent estimates for Lazio (Italy) and mixed-racial, mixed socioeconomic populations in the United States of America at up to 7 per 1,000 [32, 33]. Nevertheless, our findings highlight the limitations of current recording of FAS and FASD in England, and support the need for further development of the dataset if appropriate services are to be developed. Whilst the levels of alcohol-related harm including attributable hospital admission, mortality and crime have been increasing in recent years , no such increases were seen in any of the three diagnoses discussed here: FAS (Q86.0), maternal care for (suspected) damage to the foetus from alcohol (ICD10: O35.4) or foetus and newborn were affected by maternal use of alcohol. Because of the wide age range for children admitted with FAS (Q86.0), interpretation of temporal trends are more complicated for this condition. This is because to some extent the admissions will reflect maternal alcohol consumption patterns up to 15 years earlier, and for which we have no data. We found no evidence of an increase in admissions for FAS among children aged under 1 year, although numbers were admittedly very small, during a period when admissions for alcohol related harms in women of childbearing age increased quite substantially.
We would predict that regional variations in alcohol-related hospital admissions in women of child-bearing age would be related to FASD diagnoses. Thus, it would be expected that the North West and North East regions, known to have higher levels of alcohol misuse and harm (evidenced by hospital admission data presented here as well as other harms including incapacity benefits claimants for alcoholism) would have higher levels of FASD-related conditions. This was not found to be the case, strongly suggesting under-reporting of FASD-related conditions. The argument for under-reporting was strengthened through the outpatient data examined, where no episodes were revealed between 2003/04 and 2007/08 even though children with FASD-related conditions receive treatment as outpatients . However routine outpatient dataset for England cannot provide any intelligence on this at present. Whereas treatment specialty is a mandatory reporting item for outpatient episodes, diagnosis and procedure codes are not . As long as this remains the case, hospitals have little incentive to spend time and resources on reporting them, and hence the information is missing for the majority of records.
To understand the full extent of underreporting, an active ascertainment study is required . The use of alcohol pregnancy screening tools (such as TACE or TWEAK) to identify high risk pregnancies is crucial here , although their validation in a UK setting is required. Screening could be performed by nurses, midwives and/or general practitioners, all of whom pregnant women are likely to encounter during their pregnancy. However, exposure to alcohol does not appear to have a direct correlation to outcome . This means that, other than the most extreme cases, risk can be ascribed at birth or during pregnancy but it is not possible to provide a firm diagnosis. This is because difficulties often do not arise until later in life . Without adequate screening or recording, if diagnosis cannot be made until later in life, complications can arise if crucial information has been lost, forgotten or become unavailable. To help address these issues, neonatal discharge summaries could include a section on high risk factors for later disorders including maternal alcohol consumption. This would follow the child and be accessible to them in later life, should such a diagnosis be sought. Finally the methods used to diagnose FASD are not consistent and there appears to be a lack of awareness as to the correct diagnostic framework. This could be addressed through improved training and more consistent use of diagnosis tools (such as the four digit code) by community paediatricians, the most likely professionals to which these children will present to for diagnosis.
Current intelligence surrounding FASD-related disorders in England is severely limited. Data provided in this report serve to underline the existing gaps rather than present an understanding of the situation. If FASD-related disorders are to be effectively prevented, identified and treated, improvements to intelligence systems, practitioner awareness and screening are essential. It is only by understanding incidence and characteristics of at-risk groups that effective services and interventions can be developed.
Abel EL: An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol Teratol. 1995, 17: 437-443. 10.1016/0892-0362(95)00005-C.
Klug MG, Burd L: Fetal alcohol syndrome prevention: annual and cumulative cost savings. Neurotoxicol Teratol. 2003, 25: 763-765. 10.1016/j.ntt.2003.07.012.
British Medical Association: Fetal alcohol spectrum disorders: a guide for healthcare professionals. 2007, London: British Medical Association
Mukherjee RAS, Hollins S, Turk J: Fetal alcohol spectrum disorder: an overview. J R Soc Med. 2006, 99: 298-302. 10.1258/jrsm.99.6.298.
Sulaiman N, Florey CdV, Taylor D, Ogston S: Alcohol consumption in Dundee primigravidas and its effects on outcome of pregnancy. BMJ. 1988, 296: 1500-1503. 10.1136/bmj.296.6635.1500.
Primatesta P, Corno GD, Bonazzi MC, Waters WE: Alcohol and pregnancy: an international comparison. J Public Health. 1993, 15: 69-76.
Barrison IG, Waterson EJ, Iain MM-L: Adverse effects of alcohol in pregnancy. Addiction. 1985, 80: 11-22. 10.1111/j.1360-0443.1985.tb05284.x.
Wright J, Waterston E, Barrison I, Toplis P, Lewis I, Gordon M, MacRae K, Morris N, Murray-Lyon IM: Alcohol consumption, pregnancy and low birthweight. Lancet. 1983, 26: 663-665. 10.1016/S0140-6736(83)91964-5.
Waterson EJ, Murray-Lyon IM: Drinking and smoking patterns amongst women attending an antenatal clinic--II. during pregnancy. Alcohol Alcohol. 1989, 24: 163-173.
Plant M: Women, drinking and pregnancy. 1987, London: Tavistock Publications
North West Public Health Observatory: Local Alcohol Profiles for England. 2009, North West Public Health Observatory, Centre for Public Health Research Directorate, Liverpool John Moores University
Thomson SJ, Westlake S, Rahman TM, Cowan ML, Majeed A, Maxwell JD, Kang J-Y: Chronic liver disease--an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease. Alcohol Alcohol. 2008, 43: 416-422.
Paton A: Alcohol in the body. BMJ. 2005, 330: 85-87. 10.1136/bmj.330.7482.85.
Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, Schaefer C, Lieber CS: Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001, 25: 502-507. 10.1111/j.1530-0277.2001.tb02242.x.
Morleo M, Elliott G, Cook PA: Investigating drinking behaviours and alcohol knowledge amongst people resident in the Linacre and Derby wards of Sefton: an evaluation of the 'It's Your Choice' Intervention. 2008, Liverpool: Centre for Public Health, Liverpool John Moores University
Hughes K, Anderson Z, Morleo M, Bellis MA: Alcohol, nightlife and violence: the relative contributions of drinking before and during nights out to negative health and criminal justice outcomes. Addiction. 2008, 103: 60-65. 10.1111/j.1360-0443.2007.02030.x.
Department of Health: Pregnancy and alcohol. 2008, London: Department of Health
Anderson Z, Hughes K, Morleo M, Bellis M: Exploration of blood alcohol levels amongst people visiting nightlife in three cities in the North West. 2009, Liverpool: Centre for Public Health Research Directorate, Liverpool John Moores University
Jones L, Bellis M, Dedman D, Sumnall H, Tocque K: Alcohol-attributable fractions for England: alcohol-attributable mortality and hospital admissions. 2008, Liverpool: North West Public Health Observatory, Centre for Public Health Research Directorate, Liverpool John Moores University
Henderson J, Kesmodel U, Gray R: Systematic review of the fetal effects of prenatal binge-drinking. J Epidemiol Community Health. 2007, 61: 1069-1073. 10.1136/jech.2006.054213.
Raymond N, Beer C, Glazebrook C, Sayal K: Pregnant women's attitudes towards alcohol consumption. BMC Public Health. 2009, 9: 175-10.1186/1471-2458-9-175.
Office for National Statistics: Birth statistics: review of the National Statistician on births and patterns of family building in England and Wales, 2008. 2009, Newport: Office for National Statistics
Welch-Carre E: The neurodevelopmental consequences of prenatal alcohol exposure. Adv Neonatal Care. 2005, 5: 217-229. 10.1016/j.adnc.2005.04.007.
Primary diagnosis: 4 character. [http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=896]
Outpatient data quality report 2007-08. [http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=898]
Reid PC, Mukri F: Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3. BMJ. 2005, 330: 938-939. 10.1136/bmj.38376.505382.AE.
Information Centre: The HES Protocol (June 2009): instructions for handling the data. 2009, London: Information Centre
Sampson PD, Streissguth AP, Bookstein FL, Little RE, Clarren SK, Dehaene P, Hanson JW, Graham J, John M: Incidence of Fetal Alcohol Syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997, 56: 317-326. 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U.
Chandrasena AN, Mukherjee RAS, Turk J: Fetal alcohol spectrum disorders: an overview of interventions for affected individuals. Child Adolesc Ment Health. 2009, 14: 162-167. 10.1111/j.1475-3588.2008.00504.x.
May P, Gossage J: Estimating the prevalence of fetal alcohol syndrome: a summary. Alcohol Res Health. 2001, 25: 159-167.
Bellis MA, Hughes K, Anderson Z, Tocque K, Hughes S: Contribution of violence to health inequalities in England: demographics and trends in emergency hospital admissions for assault. J Epidemiol Community Health. 2008, 62: 1064-1071. 10.1136/jech.2007.071589.
May PA, Gossage JP, Marais AS, Adnams CM, Hoyme HE, Jones KL, Robinson LK, Khaole NC, Snell C, Kalberg WO, et al: The epidemiology of fetal alcohol syndrome and partial FAS in a South African community. Drug Alcohol Depend. 2007, 88: 259-271. 10.1016/j.drugalcdep.2006.11.007.
May PA, Fiorentino D, Gossage JP, Kalberg WO, Hoyme HE, Robinson LK, Coriale G, Jones KL, del Campo M, Tarani L, et al: Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schools. Alcohol Clin Exp Res. 2006, 30: 1562-1575. 10.1111/j.1530-0277.2006.00188.x.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/11/14/prepub
We would like to thank the North West Public Health Observatory for providing access to the Hospital Episode Statistics dataset. No funding was required to conduct the analysis.
The authors declare that they have no competing interests.
MM and KW developed the idea for the paper. MM, KW and DD wrote the manuscript. DD analysed the data. MM, KW, DD, PAC and MAB contributed to the data analysis. PAC, MAB and RM commented on and contributed to the drafting of the manuscript. MM is the guarantor. All authors read and approved the final manuscript.
Michela Morleo, Kerry Woolfall, Dan Dedman contributed equally to this work.